Skip to Main content Skip to Navigation
Journal articles

Faut-il revasculariser les sténoses carotides asymptomatiques ?

Abstract : The risk of a first ischemic stroke due to atherosclerotic carotid stenosis has decreased over the last 20 years. It is less than 1% per year overall. The benefit of carotid revascularization in patients with asymptomatic carotid stenosis receiving optimal medical treatment is controversial and is the subject of new randomized clinical trials. Pending the results of these trials, the decision to revascularize asymptomatic carotid stenosis should be individualized, taking into account the factors associated with a higher risk of ipsilateral stroke, patient's life expectancy and risks of intervention. Patient participation in randomized trials is crucial to resolve current uncertainties about the benefit of carotid revascularization in patients with asymptomatic carotid stenosis.
Document type :
Journal articles
Complete list of metadatas

Cited literature [38 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-02971278
Contributor : Clara Martinez Rico <>
Submitted on : Monday, October 19, 2020 - 12:52:47 PM
Last modification on : Wednesday, October 21, 2020 - 3:39:50 AM
Long-term archiving on: : Wednesday, January 20, 2021 - 6:40:26 PM

File

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document

Identifiers

Collections

Citation

Jean-Louis Mas. Faut-il revasculariser les sténoses carotides asymptomatiques ?. Bulletin de l'Académie Nationale de Médecine, Elsevier Masson, 2020, 204 (1), pp.102-108. ⟨10.1016/j.banm.2019.04.015⟩. ⟨inserm-02971278⟩

Share

Metrics

Record views

18